Cellectar Biosciences Inc... (CLRB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.26

1.51%

After-hours Dec 13, 2024, 07:49 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-11.00K	33.33K	96.31K	125.97K	-	-	12.58K
Cost of Revenue	192.38K	238.87K	227.64K	207.93K	189.36K	82.27K	1.55M	356.67K	362.50K	-	-	-	-	-	-	-	-	-	-
Gross Profit	-192.38K	-238.87K	-227.64K	-207.93K	-189.36K	-82.27K	-1.55M	-356.67K	-362.50K	-	-	-	-11.00K	33.33K	96.31K	125.97K	-	-	12.58K
Operating Income	-38.96M	-28.81M	-24.13M	-15.29M	-14.18M	-13.33M	-13.60M	-9.45M	-8.76M	-9.89M	-12.40M	-8.75M	-7.04M	-5.45M	-10.17M	-16.59M	-20.29M	-8.93M	-5.09M
Interest Income	-	152.52K	2.28K	10.90K	42.71K	-	-	-	-	-	-	1K	4.50K	2.42K	1.01K	130.61K	729.92K	637.75K	49.88K
Pretax Income	-38.04M	-28.66M	-24.12M	-15.09M	-14.09M	-13.24M	-13.56M	-6.18M	-5.50M	-8.11M	-10.78M	-8.80M	-7.75M	-12.65M	-26.28M	-22.96M	-29.72M	-8.55M	-3.16M
Net Income	-37.98M	-28.60M	-23.97M	-14.76M	-13.87M	-13.24M	-13.56M	-6.18M	-5.50M	-8.11M	-10.78M	-8.80M	-7.44M	2.10M	-22.27M	-16.45M	-19.56M	-8.29M	-3.05M
Selling & General & Admin	10.75M	9.59M	6.54M	5.15M	5.18M	4.82M	4.14M	4.70M	3.40M	3.70M	4.44M	3.63M	2.69M	2.49M	2.18M	2.19M	2.87M	2.49M	1.44M
Research & Development	28.21M	19.22M	17.59M	10.14M	9.00M	6.84M	9.47M	4.75M	5.16M	5.96M	6.86M	5.12M	3.60M	3.00M	8.08M	14.53M	17.43M	6.44M	1.14M
Other Expenses	-0.00	-	6.63K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	38.96M	28.81M	24.13M	15.29M	14.18M	11.66M	13.60M	9.45M	8.55M	9.67M	11.30M	8.75M	6.29M	5.48M	10.26M	16.72M	20.29M	8.93M	2.58M
Interest Expense	-	-	-	-	-	29.69K	16.61K	7.90K	841.00	446.31K	9.35K	9.34K	430.02K	2.42K	1.01K	130.61K	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	38.96M	28.81M	24.13M	15.29M	14.18M	11.66M	13.60M	9.45M	8.55M	9.67M	11.30M	8.75M	6.29M	5.48M	10.26M	16.72M	20.29M	8.93M	2.58M
Income Tax	-60.00K	-60.00K	-152.20K	-337.63K	-218.51K	-1.55M	-38.68K	-3.27M	-3.42M	-1.56M	-522.76K	9.34K	1.14M	-7.55M	12.11M	-139.61K	-737.05K	-643.75K	487.02K
Shares Outstanding (Basic)	12.22M	7.06M	5.55M	1.98M	767.51K	296.20K	140.31K	43.67K	7.82K	4.59K	2.79K	2.06K	1.20K	147.00	22.00	14.00	12.00	12.00	12.00
Shares Outstanding (Diluted)	12.22M	7.06M	5.55M	1.98M	767.51K	296.20K	140.31K	43.67K	7.82K	4.59K	2.79K	2.06K	1.20K	147.00	22.00	14.00	12.00	12.00	12.00
EPS (Basic)	-3.11	-4.05	-4.32	-7.45	-18.08	-44.7	-96.66	-141.54	-702.78	-1.77K	-3.86K	-4.28K	-6.21K	-31.02K	-1.01M	-1.18M	-1.63M	-690.50K	-254.45K
EPS (Diluted)	-3.11	-4.05	-4.32	-7.45	-18.08	-44.7	-96.66	-141.54	-702.78	-1.77K	-3.86K	-4.28K	-6.21K	-31.02K	-1.01M	-1.18M	-1.63M	-690.50K	-254.45K
EBITDA	-38.77M	-28.67M	-23.98M	-15.15M	-13.90M	-13.16M	-12.05M	-9.09M	-8.19M	-9.30M	-10.88M	-8.29M	-6.33M	-12.96M	-10.17M	-16.59M	-19.54M	-8.28M	-2.94M
Depreciation & Amortization	192.38K	238.87K	227.64K	207.93K	189.36K	82.27K	1.55M	356.67K	362.50K	367.20K	424.76K	497.25K	584.84K	35.34K	32.35K	16.89K	15.37K	9.52K	3.24K